Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melville Q Wyche

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Therapeutics|September 13, 2005
Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot studyFatemeh Tavakkoli, Masoud Nahavandi, Melville Q Wyche, et al.
Hematology (Amsterdam, Netherlands)|February 18, 2004
Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyureaFatemeh Tavakkoli, Masoud Nahavandi, Melville Q Wyche, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 28, 2005
Quantitative analysis of trimethylsilyl derivative of hydroxyurea in plasma by gas chromatography-mass spectrometryHutchinson James, Masoud Nahavandi, Melville Q Wyche, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Nitric Oxide Metabolites in Sickle Cell Anemia Patients after Oral Administration of Hydroxyurea; HemoglobinopathyMasoud Nahavandi, Melville Q. Wyche, Elliott Perlin, et al.
Hematology (Amsterdam, Netherlands)|December 12, 2003
Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisisMasoud Nahavandi, Fatemeh Tavakkoli, Melville Q Wyche, et al.
British Journal of Haematology|November 20, 2002
Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyureaMasoud Nahavandi, Fatemeh Tavakkoli, Melville Q Wyche, et al.
Ochsner Journal|September 15, 2023
Lower Double-Wall Puncture Rate During Ultrasound-Guided Internal Jugular Vein Cannulation Using Sharper, Narrower-Gauge, and/or Length-Optimized Needles: A 6-Year Quality Improvement Clinical Series in Adult PatientsJames M Riopelle, Valeriy V Kozmenko, Melville Q Wyche, et al.
Hematology (Amsterdam, Netherlands)|December 21, 2006
Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytesMasoud Nahavandi, Fatemeh Tavakkoli, Richard M Millis, et al.
Journal of Anaesthesiology, Clinical Pharmacology|September 15, 2016
Novel drug development for neuromuscular blockadeAmit Prabhakar, Alan D Kaye, Melville Q Wyche, et al.
Current Pain and Headache Reports|April 6, 2018
America's Opioid Epidemic: a Comprehensive Review and Look into the Rising CrisisPeter S Ostling, Kelly S Davidson, Best O Anyama, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Therapeutics|September 13, 2005
Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot studyFatemeh Tavakkoli, Masoud Nahavandi, Melville Q Wyche, et al.
Hematology (Amsterdam, Netherlands)|February 18, 2004
Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyureaFatemeh Tavakkoli, Masoud Nahavandi, Melville Q Wyche, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 28, 2005
Quantitative analysis of trimethylsilyl derivative of hydroxyurea in plasma by gas chromatography-mass spectrometryHutchinson James, Masoud Nahavandi, Melville Q Wyche, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Nitric Oxide Metabolites in Sickle Cell Anemia Patients after Oral Administration of Hydroxyurea; HemoglobinopathyMasoud Nahavandi, Melville Q. Wyche, Elliott Perlin, et al.
Hematology (Amsterdam, Netherlands)|December 12, 2003
Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisisMasoud Nahavandi, Fatemeh Tavakkoli, Melville Q Wyche, et al.
British Journal of Haematology|November 20, 2002
Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyureaMasoud Nahavandi, Fatemeh Tavakkoli, Melville Q Wyche, et al.
Ochsner Journal|September 15, 2023
Lower Double-Wall Puncture Rate During Ultrasound-Guided Internal Jugular Vein Cannulation Using Sharper, Narrower-Gauge, and/or Length-Optimized Needles: A 6-Year Quality Improvement Clinical Series in Adult PatientsJames M Riopelle, Valeriy V Kozmenko, Melville Q Wyche, et al.
Hematology (Amsterdam, Netherlands)|December 21, 2006
Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytesMasoud Nahavandi, Fatemeh Tavakkoli, Richard M Millis, et al.
Journal of Anaesthesiology, Clinical Pharmacology|September 15, 2016
Novel drug development for neuromuscular blockadeAmit Prabhakar, Alan D Kaye, Melville Q Wyche, et al.
Current Pain and Headache Reports|April 6, 2018
America's Opioid Epidemic: a Comprehensive Review and Look into the Rising CrisisPeter S Ostling, Kelly S Davidson, Best O Anyama, et al.
Pageof 2